Forte Biosciences, Inc. 8-K

What Happened
Forte Biosciences, Inc. (FBRX) filed a Form 8-K on May 14, 2026 under Item 2.02 to furnish a press release dated May 11, 2026 reporting the company's financial results for the quarter ended March 31, 2026. The press release is attached as Exhibit 99.1 to the current report.

Key Details

• Form 8-K filed on May 14, 2026 reporting results of operations and financial condition (Item 2.02).
• Press release dated May 11, 2026 furnished as Exhibit 99.1.
• Financial results cover the quarter ended March 31, 2026.
• Cover Page Interactive Data File is included (Exhibit 104, Inline XBRL).

Why It Matters
This 8-K provides investors with Forte’s latest quarterly results and any reported changes in revenue, expenses, or cash position contained in the May 11 press release. Retail investors should read the attached press release for the specific earnings, revenue, net income (or loss), and any management commentary or guidance that may affect valuation or near-term trading decisions.